Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Roder

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
The British Journal of Surgery|August 1, 1996
Benefits of D2 lymph node dissection for patients with gastric cancer and pN0 and pN1 lymph node metastasesJ R Siewert, R Kestlmeier, R Busch, et al.
Hepato-Gastroenterology|July 21, 2001
New aspects of prognostic factors in adenocarcinomas of the small bowelB L Brücher, H J Stein, J D Roder, et al.
Hepato-Gastroenterology|October 16, 1999
The role of surgery in the treatment of liver metastases for colorectal cancer patientsJ Harms, T Obst, S Thorban, et al.
Deutsche Medizinische Wochenschrift (1946)|April 26, 1996
[Comparison of the quality of life after subtotal and total gastrectomy for stomach carcinoma]J D Roder, H J Stein, F Eckel, et al.
Cancer Research|June 1, 1994
Prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in completely resected gastric cancerH Nekarda, M Schmitt, K Ulm, et al.
World Journal of Surgery|October 19, 2000
Preoperative evaluation of pancreatic masses with positron emission tomography using 18F-fluorodeoxyglucose: diagnostic limitationsA Sendler, N Avril, H Helmberger, et al.
World Journal of Surgery|July 1, 1995
Lymphadenectomy for gastric cancer in clinical trials: updateJ D Roder, J J Bonenkamp, J Craven, et al.
Arzneimittel-Forschung|June 1, 1995
Pharmacokinetics and plasma protein binding of the new potent class III antiarrhythmic agent 3-[4-(1H-imidazol-1-yl)benzoyl]-7-isopropyl-3, 7-diazabicyclo[3.3.1]nonane dihydroperchlorateC L Chen, S Sangiah, J D Roder, et al.
Journal of Chromatography|December 2, 1992
High-performance liquid chromatographic determination of BRB-I-28, a novel antiarrhythmic agent, in dog plasma and urineC L Chen, B A Lesseley, C R Clarke, et al.
European Journal of Drug Metabolism and Pharmacokinetics|April 1, 1995
Metabolism and metabolite pharmacokinetics of BRB-I-28, a class Ib antiarrhythmic agentC L Chen, S Sangiah, D W Bourne, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
The British Journal of Surgery|August 1, 1996
Benefits of D2 lymph node dissection for patients with gastric cancer and pN0 and pN1 lymph node metastasesJ R Siewert, R Kestlmeier, R Busch, et al.
Hepato-Gastroenterology|July 21, 2001
New aspects of prognostic factors in adenocarcinomas of the small bowelB L Brücher, H J Stein, J D Roder, et al.
Hepato-Gastroenterology|October 16, 1999
The role of surgery in the treatment of liver metastases for colorectal cancer patientsJ Harms, T Obst, S Thorban, et al.
Deutsche Medizinische Wochenschrift (1946)|April 26, 1996
[Comparison of the quality of life after subtotal and total gastrectomy for stomach carcinoma]J D Roder, H J Stein, F Eckel, et al.
Cancer Research|June 1, 1994
Prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in completely resected gastric cancerH Nekarda, M Schmitt, K Ulm, et al.
World Journal of Surgery|October 19, 2000
Preoperative evaluation of pancreatic masses with positron emission tomography using 18F-fluorodeoxyglucose: diagnostic limitationsA Sendler, N Avril, H Helmberger, et al.
World Journal of Surgery|July 1, 1995
Lymphadenectomy for gastric cancer in clinical trials: updateJ D Roder, J J Bonenkamp, J Craven, et al.
Arzneimittel-Forschung|June 1, 1995
Pharmacokinetics and plasma protein binding of the new potent class III antiarrhythmic agent 3-[4-(1H-imidazol-1-yl)benzoyl]-7-isopropyl-3, 7-diazabicyclo[3.3.1]nonane dihydroperchlorateC L Chen, S Sangiah, J D Roder, et al.
Journal of Chromatography|December 2, 1992
High-performance liquid chromatographic determination of BRB-I-28, a novel antiarrhythmic agent, in dog plasma and urineC L Chen, B A Lesseley, C R Clarke, et al.
European Journal of Drug Metabolism and Pharmacokinetics|April 1, 1995
Metabolism and metabolite pharmacokinetics of BRB-I-28, a class Ib antiarrhythmic agentC L Chen, S Sangiah, D W Bourne, et al.
Pageof 8